Business
£1.66 million Amended Funding Package
Hamak Strategy Limited has restructured its funding by converting a £2.5 million convertible loan note into a non-convertible loan of £1,657,671.23 with YA II PN Ltd, removing conversion rights and establishing a clearer repayment pathway over ten months commencing 60 days after the agreement. The interest rate remains at 4% per annum, with only £20,000 in legal fees incurred. Hamak can retain the first £110,000 raised through its ATM facility, with 50% of subsequent ATM proceeds applied to the loan. Additionally, 165,767,123 warrants exercisable at £0.01 per share, a 54% premium, have been issued to the lender. Disclaimer*
About this update from Hamak Strategy Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES, ANY TERRITORY OR POSSESSION THEREOF OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. 2 July 2026 Hamak Strategy Limited ("Hamak" or the "Company") £1.66 million Amended Funding Package Removes Convertible Debt and Strengthens Funding Flexibility Hamak Strategy Limited (LSE: HAMA / OTCQB: HASTF), a company combining advanced gold exploration in West Africa with a disciplined Digital Asset Treasury Management strategy, is pleased to announce that it has entered into an amendment and restatement of its existing funding arrangements with YA II PN Ltd (the "Lender"), an institutional investor managed by Yorkville Advisors Global, LP. The amended package restates the outstanding balance of the previous £2.5 million convertible loan note announced on 4 December 2025 into a non-convertible loan of £1,657,671.23. The Board believes the revised structure materially improves funding visibility, removes the conversion rights attached to the previous CLN and provides a clearer repayment pathway while allowing the Company to retain working capital flexibility for its operational and strategic objectives. Highlights • Outstanding CLN balance restated into a non-convertible loan of £1,657,671.23. • No penalties and no restructuring fees, other than £20,000 of legal fees in connection with the required documentation. • Interest rate remains at 4% per annum. • Amortisation commences 60 days after entry into the new loan agreement and then follows an agreed repayment schedule over the subsequent ten months. • Hamak may retain the first £110,000 of cash raised through its existing At The Market Facility ("ATM"), with 50% of ATM proceeds thereafter applied to reduce the outstanding loan balance. • Warrants are exercisable at 1p per share, a 54% premium to the offer price of the Company's shares on 1 July 2026 and are exercisable on a cash basis only. New Loan Agreement The new funding package represents an amendment and restatement, without penalties, of the previous £2.5 million Convertible Loan Note announced on 4 December 2025 (the "CLN"). The new loan amount is £1,657,671.23, representing the outstanding balance of the previous CLN. Imp...
View stock analysis, news, and events for Hamak Strategy Limited